News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers
Dec 16, 2024, 17:31

GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers

Erman Akkus shared on X:

“GemCis-NabPaclitaxel vs. GemCis in 1L of advanced biliary tract cancers

SWOG S1815

No PFS or OS benefit

PFS benefit in gallbladder cancer subgroup.”

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers 

Authors: Rachna T. Shroff, Gentry King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura Goff,  Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind M. Javle, Imane El Dika, Benjamin Tan, Puneet Cheema, Anuj Patel, Renuka Iyer, R. Katie Kelley, Jaykumar Thumar,  Anthony El-Khoueiry, Katherine A. Guthrie, E. Gabriela Chiorean, Howard Hochster, and Philip A. Philip.

GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers

Aaron J. Scott Amit Mahipal Anthony El-Khoueiry Anuj Patel Aparna Kalyan Benjamin Tan cancer E. Gabriela Chiorean Erman Akkus Gentry King Howard Hochster Imane El Dika Jaykumar Thumar Katherine A. Guthrie Khalid Matin Laura Goff Milind M. Javle Mitesh J. Borad OncoDaily Oncology Philip A. Philip Puneet Cheema R. Katie Kelley Rachna T. Shroff Renuka Iyer Sarah Colby
Special Coverage
Blog
Mar 29, 2025, 06:23
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Blog
Mar 29, 2025, 06:05
Yat Man Tsang: Radiation therapists’ perspectives on AI
Insight
Mar 29, 2025, 06:01
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients
Blog
Mar 29, 2025, 04:55
Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM
Blog
Mar 29, 2025, 04:16
Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC
OncoDaily Pulse
Mar 29, 2025, 03:34
OncoDaily partners with EYOC aiming for innovation, research and equitable care
Career
Mar 29, 2025, 03:20
Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope
Insight
Mar 28, 2025, 20:51
Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center
Blog
Mar 28, 2025, 20:17
Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025
Blog
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Blog
Mar 28, 2025, 19:58
Nina Niu Sanford: Here is HCC 101 video
Blog
Mar 28, 2025, 19:38
Julien Mazieres: Another brick in the wall of HER2-mutant NSCLC